“Tissue-Engineered ‘Metastases’: Treatment of Hepatic Colon Tumors With a Dual Action Autotaxin Inhibitor-Lysophosphatidic Acid Receptor Antagonist ”. Journal of Cancer Research Updates 1, no. 1 (August 20, 2021): 69–77. Accessed January 14, 2026. https://neoplasiaresearch.com/index.php/jcru/article/view/618.